- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- 8-K/A Current report
- 2.1 Exhibit 2.1
- 3.1 Exhibit 3.1
- 3.2 Exhibit 3.2
- 3.3 Exhibit 3.3
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.7 Exhibit 10.7
- 10.8 Exhibit 10.8
- 10.9 Exhibit 10.9
- 10.10 Exhibit 10.10
- 10.11 Exhibit 10.11
- 10.12 Exhibit 10.12
- 10.13 Exhibit 10.13
- 10.14 Exhibit 10.14
- 10.15 Exhibit 10.15
- 10.16 Exhibit 10.16
- 10.17 Exhibit 10.17
- 10.18 Exhibit 10.18
- 10.19 Exhibit 10.19
- 10.20 Exhibit 10.20
- 10.21 Exhibit 10.21
- 10.22 Exhibit 10.22
- 10.23 Exhibit 10.23
- 10.24 Exhibit 10.24
- 10.25 Exhibit 10.25
- 10.26 Exhibit 10.26
- 10.27 Exhibit 10.27
- 10.28 Exhibit 10.28
- 10.29 Exhibit 10.29
- 10.30 Exhibit 10.30
- 10.31 Exhibit 10.31
- 10.32 Exhibit 10.32
- 10.33 Exhibit 10.33
- 10.34 Exhibit 10.34
- 10.35 Exhibit 10.35
- 10.36 Exhibit 10.36
- 10.37 Exhibit 10.37
- 10.38 Exhibit 10.38
- 10.39 Exhibit 10.39
- 10.40 Exhibit 10.40
- 10.41 Exhibit 10.41
- 10.42 Exhibit 10.42
- 10.43 Exhibit 10.43
- 10.44 Exhibit 10.44
- 10.45 Exhibit 10.45
- 99.1 Enumeral Biomedical Raises $21.5 Million from New and Current Investors, Begins Public Trading
- 14 Nov 14 Enumeral Reports Third Quarter 2014 Financial Results
- 12 Nov 14 Entry into a Material Definitive Agreement
- 18 Sep 14 Enumeral Awarded Phase II SBIR Contract from the National Cancer Institute to
- 8 Aug 14 Enumeral Biomedical Raises $21.5 Million from New and Current Investors, Begins Public Trading
- 7 Aug 14 Enumeral Biomedical Raises $21.5 Million from New and Current Investors, Begins Public Trading
- 23 Jul 14 Other Events
- 16 Jul 14 Unregistered Sales of Equity Securities
STATE OF DELAWARE
CERTIFICATE OF MERGER
OF
DOMESTIC CORPORATIONS
Pursuant to Title 8, Section 251(c) of the Delaware General Corporation Law, the undersigned corporation executed the following Certificate of Merger:
FIRST: The name of the surviving corporation isEnumeral Biomedical Corp., a Delaware corporation (the “Surviving Corporation”), and the name of the corporation being merged into the Surviving Corporation isEnumeral Acquisition Corp., a Delaware corporation (“Acquisition Subsidiary”).
SECOND: The Agreement of Plan of Merger and Reorganization by and among Enumeral Biomedical Holdings, Inc., the Acquisition Subsidiary and the Surviving Corporation, and solely with respect to Section 6.3(f) thereof, Arthur H. Tinkelenberg (the “Agreement of Merger”), has been approved, adopted, executed and acknowledged by each of the constituent corporations.
THIRD: The name of the surviving corporation isEnumeral Biomedical Corp., a Delaware corporation
FOURTH: The Certificate of Incorporation of Acquisition Subsidiary, as in effect immediately prior to the merger, shall be the Certificate of Incorporation of the Surviving Corporation.
FIFTH: The merger is to become effective upon filing of this Certificate of Merger with the Secretary of State of the State of Delaware.
SIXTH: The executed Agreement of Merger is on file at One Kendall Square, Building 400, 4th Floor, Cambridge, MA 02139, the place of business of the Surviving Corporation.
SEVENTH: A copy of the Agreement of Merger will be furnished by the surviving corporation on request, without cost, to any stockholder of the constituent corporations.
IN WITNESS WHEREOF, said Surviving Corporation has caused this certificate to be signed by an authorized officer, the 31st day of July, 2014.
ENUMERAL BIOMEDICAL CORP. | ||
By: | /s/ Arthur H. Tinkelenberg | |
Name: Arthur H. Tinkelenberg | ||
Title: Chief Executive Officer |